Biomarkers, Revisited. Unfortunately.

Posted on: 02, Jun, 2011

Your genome - destiny, right? That's what some of us thought - every disease was going to have one or more associated genes, those genes would code for new drug targets, and we'd all have a great time picking them off one by one. It didn't work out that way, of course, but there are still all these papers out there in the literature, linking Gene A with the chances of getting Disease B. So how much are those worth? While we're at it, everyone also wanted (and still wants) biomarkers of all kind...

Tags: biological news , , biomarkers , gene , paper

Original post link

Featured Investment Blogs

...

Paul Kedrosky's Infectious Greed

Musing about technology, finance, venture capital, & the money culture with Paul Kedrosky...

Jeff Matthews Is Not Making This Up

An insider's look into The World of Wall Street in all its glory, and anything else that strikes our fancy... For ou...

Insightful Analysis and Commentary for U.S. and Global Equity Investors...

...

Environmental Economics

Economists on Environmental and Natural Resources News, Opinion, Analysis (and Other Stuff)...

Stock Market Beat

Our beat: The stock market. Our job: Beat it....

TechCrunch is a group-edited blog that profiles the companies, products and events defining and transforming the new ...

Featured Investment Videos

...

...

...

...